Treatment for severe COVID-19 with a biomimetic sorbent haemoperfusion device in patients on haemodialysis

Haemodialysis (HD) patients present more morbidity and mortality risk in coronavirus disease 2019 (COVID-19). In patients who may develop severe symptoms, the process called ‘viral sepsis’ seems to be a crucial mechanism. In those cases, the HD procedure provides an excellent tool to explore the ben...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandoval, Diego, Rama, Inés, Quero, María, Hueso, Miguel, Gómez, Francisco, Cruzado, Josep M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Exceptional Cases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929023/
https://www.ncbi.nlm.nih.gov/pubmed/33953913
http://dx.doi.org/10.1093/ckj/sfab010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929023/
https://www.ncbi.nlm.nih.gov/pubmed/33953913
http://dx.doi.org/10.1093/ckj/sfab010

Ejemplares similares